Sws Partners Novo Nordisk A S Transaction History

Sws Partners

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$122.71 - $146.91 $171,671 - $205,527	1,399 New	1,399 $199,000
Q2 2023 Aug 10, 2023	BUY	$155.98 - $172.65 $3.8 Million - $4.21 Million	24,394 New	24,394 $3.95 Million
Q2 2022 Jul 28, 2022	SELL	$103.24 - $121.81 $58,743 - $69,309	-569 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$93.1 - $112.54 $52,973 - $64,035	569 New	569 $63,000
Q2 2018 Aug 13, 2018	SELL	$44.29 - $50.42 $25,201 - $28,688	-569 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$47.53 - $53.73 $27,044 - $30,572	569	569 $31,000

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $245B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Sws Partners, based on Form 13F filings with the SEC.

Stay updated on Sws Partners with notifications on news.